Detalhe da pesquisa
1.
Mice with Whole-Body Disruption of AMPK-Glycogen Binding Have Increased Adiposity, Reduced Fat Oxidation and Altered Tissue Glycogen Dynamics.
Int J Mol Sci
; 22(17)2021 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34502525
2.
ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathways.
FASEB J
; 33(12): 14825-14840, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31670977
3.
CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages.
J Autoimmun
; 88: 131-138, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29103803
4.
The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injury.
Biomed Pharmacother
; 175: 116730, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38749175
5.
Disrupting AMPK-Glycogen Binding in Mice Increases Carbohydrate Utilization and Reduces Exercise Capacity.
Front Physiol
; 13: 859246, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392375
6.
An AMPKα2-specific phospho-switch controls lysosomal targeting for activation.
Cell Rep
; 38(7): 110365, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172150
7.
Blocking AMPK ß1 myristoylation enhances AMPK activity and protects mice from high-fat diet-induced obesity and hepatic steatosis.
Cell Rep
; 41(12): 111862, 2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36543129
8.
Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolism.
Mol Metab
; 41: 101048, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32610071
9.
The myokine meteorin-like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKα2.
FEBS J
; 287(10): 2087-2104, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32196931
10.
Inhibition of Adenosine Monophosphate-Activated Protein Kinase-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Signaling Leads to Hypercholesterolemia and Promotes Hepatic Steatosis and Insulin Resistance.
Hepatol Commun
; 3(1): 84-98, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30619997
11.
Anti-Gal antibody-mediated skin graft rejection requires a threshold level of Gal expression.
Xenotransplantation
; 15(1): 20-6, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18333910
12.
AMPK signaling to acetyl-CoA carboxylase is required for fasting- and cold-induced appetite but not thermogenesis.
Elife
; 72018 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29433631
13.
Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.
J Clin Invest
; 113(10): 1440-6, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15146241
14.
Blockade of the passive cell death pathway does not prevent tolerance induction to islet grafts.
Transplantation
; 83(5): 653-5, 2007 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17353789
15.
Overexpression of glutathione peroxidase with two isoforms of superoxide dismutase protects mouse islets from oxidative injury and improves islet graft function.
Diabetes
; 54(7): 2109-16, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15983212
16.
Cardiac and skin xenograft survival in different recipient mouse strains.
Transplantation
; 82(10): 1362-9, 2006 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-17130786
17.
Gal mismatch alone causes skin graft rejection in mice.
Transplantation
; 74(5): 637-45, 2002 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12352879
18.
Allogeneic sensitization is more effective than xenogeneic sensitization in eliciting Gal-mediated skin graft rejection.
Transplantation
; 77(5): 751-3, 2004 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15021840
19.
Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies.
Transpl Immunol
; 10(1): 63-72, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12182467
20.
The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in mice.
Diabetes
; 62(6): 2026-35, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23364452